A model predictive control strategy toward optimal structured treatment interruptions in anti-HIV therapy

IEEE Transactions on Biomedical Engineering

Volumn 57, Issue 5, 2010, Pages 1040-1050

  Pannocchia, Gabriele ^a   Laurino, Marco ^a   Landi, Alberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antiretroviral therapy; Human immunodeficiency virus control; Model predictive control (MPC); Therapy optimization

Indexed keywords

ANTI-HIV; ANTIRETROVIRALS; CONTROL MODEL; CONTROL OBJECTIVES; DIFFERENT EFFECTS; HIGHLY ACTIVE ANTI-RETROVIRAL THERAPIES; HUMAN IMMUNODEFICIENCY VIRUS; MODEL PREDICTIVE CONTROL (MPC); MODEL STATE; SIDE EFFECT; SIMULATION STUDIES; STRUCTURED TREATMENT INTERRUPTIONS; TRANSIENT RESPONSE; ULTIMATE BEHAVIOR;

DRUG INTERACTIONS; DRUG THERAPY; OPTIMIZATION; PREDICTIVE CONTROL SYSTEMS; VIRUSES;

MODEL PREDICTIVE CONTROL;

ANTIINFECTIVE AGENT;

ALGORITHM; ARTICLE; CD4+ T LYMPHOCYTE; COMPUTER SIMULATION; DRUG RESPONSE; DRUG SAFETY; DRUG USE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; MODEL PREDICTIVE CONTROL; OUTCOME ASSESSMENT; VIRUS CONCENTRATION; VIRUS INFECTION;

ALGORITHMS; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMPUTER SIMULATION; DRUG THERAPY, COMPUTER-ASSISTED; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; TREATMENT OUTCOME;

EID: 77951268414     PISSN: 00189294     EISSN: None     Source Type: Journal    
DOI: 10.1109/TBME.2009.2039571     Document Type: Article

References (47)

1. A. Landi,A. Mazzoldi, C. Andreoni,M.Bianchi, A. Cavallini, M. Laurino, L. Ricotti, R. Iuliano, B. Matteoli, and L. Ceccherini-Nelli, "Modelling and control of HIV dynamics," Comput. Methods Programs Biomed., vol.89, no.2, pp. 162-168, 2008.
2. D.Wodarz andM. A. Nowak, "Mathematical models of HIV pathogenesis and treatment," BioEssays, vol.24, pp. 1178-1187, 2002. (Pubitemid 35464947)
3. X. Xia, "Modelling of HIV infection: Vaccine readiness, drug effectiveness and therapeutical failures," J. Proc. Cont., vol.17, pp. 253-260, 2007. (Pubitemid 46205319)
4. B. M. Adams, H. T. Banks, M. Davidian, H.-D. Kwon, H. T. Tran, S. N. Wynne, and E. S. Rosenberg, "HIV dynamics: Modeling, data analysis, and optimal treatment protocols," J. Comput. Appl. Math., vol.184, pp. 10-49, 2005. (Pubitemid 41100712)
5. D. Wodarz, K. M. Page, R. Arnaout, A. R. Thomsen, J. D. Lifson, and M. A. Nowak, "A new theory of cytotoxic T-lymphocyte memory: Implications for HIV treatment," Philos. Trans. R. Soc. Lond. B Biol. Sci., vol.355, pp. 329-343, 2000. (Pubitemid 30199475)
6. D. Wodarz, R. Arnaout, M. A. Nowak, and J. D. Lifson, "Transient antiretroviral treatment during acute simian immudeficiency virus infection facilitates long-term control of the virus," Philos. Trans. R. Soc. Lond. B Biol. Sci., vol.355, pp. 1021-1029, 2000.
7. D. Wodarz and M. A. Nowak, "Specific therapy regimes could lead to long-term immunological control of HIV," Proc. Nat. Acad. Sci., vol.96, pp. 14464-14469, 1999. (Pubitemid 30000673)
8. D. E. Kaufmann, M. Lichterfeld, M. A. M. M. Addo, M. N. Johnston, P. K. Lee, B. S. Wagner, E. T. Kalife, D. Strick, E. S. Rosenberg, and B. D. Walker, "Limited durability of viral control following treated acute HIV infection," PLos Med., vol.1, no.2, pp. 137-148, 2004. (Pubitemid 40412717)
9. Staccato Study Group, "CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: Results of the Staccato randomised trial," Lancet, vol.368, pp. 460-465, 2006.
10. C. A. Benson, "Structured treatment interruptions-New findings," Top. HIV Med., vol.14, no.3, pp. 107-111, 2006.
11. SMART Study Group, "The strategies for management of antiretroviral therapyCD4+ count-guided interruption of antiretroviral treatment," New Engl. J. Med., vol.355, no.22, pp. 2283-2296, 2006.
12. R. Zurakowski andA. R. Teel, "A model predictive control-based scheduling method for HIV therapy," J. Theor. Biol., vol.238, pp. 368-382, 2006. (Pubitemid 41828437)
13. J. H. Ko, W. H. Kim, and C. C. Chung, "Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability," IEEE Trans. Biom. Eng., vol.53, no.3, pp. 380-386, Mar. 2006.
14. A. M. Jeffrey, X. Xia, and I. K. Craig, "IV. Structured treatment interruptions: A control mathematical approach to protocol design," J. Proc. Cont., vol.17, pp. 586-590, 2007. (Pubitemid 46994691)
15. M. A. Nowak and C. R. Bangham, "Population dynamics of immune responses to persistent viruses," Science, vol.272, pp. 74-79, 1996.
16. M. A. Nowak, "Helper-dependent vs. helper-independent CTL responses in HIV infection: Implications for drug therapy and resistance," J. Theor. Biol., vol.213, pp. 447-459, 2001.
17. A. V. M. Herz, S. Bonhoeffer, R. M. Anderson, R. M. May, and M. A. Nowak, "Viral dynamics in vivo: Limitations on estimates of intracellular delay and virus decay," Proc. Nat. Acad. Sci., vol.93, pp. 7247-7251, 1996. (Pubitemid 26243534)
18. H. Wu and A. Ding, "Population HIV-1 dynamics in vivo: Applicable models and inferential tools for virological data fromAIDS clinical trials," Biometrics, vol.55, pp. 410-418, 1999. (Pubitemid 29302563)
19. A. S. Perelson and R. M. Ribeiro, "Estimating drug efficacy and viral dynamic parameters: HIV and HCV," Statist. Med., vol.27, pp. 4647-4657, 2007.
20. Y. El Safadi, V. Vivet-Boudou, and R. Marquet, "HIV-1 reverse transcriptase inhibitors," Appl. Microb. Biotech., vol.75, pp. 723-737, 2007. (Pubitemid 47164912)
21. V. Muller, A. F. M. Maree, and R. J. De Boer, "Small variations in multiple parameters account for wide variations in HIV-1 set-points: A novel modelling approach," Proc. Roy. Soc. L., vol.268, pp. 235-242, 2001. (Pubitemid 32154501)
22. R. D. Hockett, J. M. Kilby, C. A. Derdeyn, M. S. Michael S. Saag, K. Squires, S. Chiz, M. A. Nowak, G. M. Shaw, and R. P. Bucy, "Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA," J. Exp. Med., vol.189, no.10, pp. 1545-1554, 1999. (Pubitemid 29240879)
23. D. Q. Mayne, J. B. Rawlings, C. V. Rao, and P. O. M. Scokaert, "Constrained model predictive control: Stability and optimality," Automatica, vol.36, pp. 789-814, 2000. (Pubitemid 30587683)
24. S. J. Qin and T. A. Badgwell, "A survey of industrial model predictive control technology," Contr. Eng. Pract., vol.11, pp. 733-764, 2003. (Pubitemid 36906334)
25. G. Pannocchia and J. B. Rawlings, "Disturbance models for offset-free model predictive control," AIChE J., vol.49, pp. 426-437, 2003. (Pubitemid 36228207)
26. M. Morari and A. Gentilini, "Challanges and opportunities in process control: Biomedical processes," AIChE J., vol.47, pp. 2140-2143, 2001. (Pubitemid 36858771)
27. F. Doyle, L. Jovanovic, D. Seborg, R. S. Parker, B. W. Bequette, A. M. Jeffrey, X. Xia, I. K. Craig, and T. McAvoy, "A tutorial on biomedical process control," J. Proc. Cont., vol.17, pp. 571-572, 2007. (Pubitemid 46962974)
28. R. Parker, F. J. Doyle, and N. A. Peppas, "A model-based algorithm for blood glucose control in type I diabetic patients," IEEE Trans. Biom. Eng., vol.56, no.2, pp. 148-156, Feb. 1999. (Pubitemid 29058920)
29. R. Hovorka, V. Canonico, L. Chassin, U. Hauter, M. Massi-Benedetti, M. O. Federici, T. Pieber, H. Schaller, L. Schaupp, T. Vering, and M. Wilinska, "Nonlinear model predicitive control of glucose concentration in subjects with type I diabetes," Physiol. Meas., vol.25, pp. 905-920, 2004. (Pubitemid 39121173)
30. B. W. Bequette, "A critical assessment of algorithms and challanges in the development of a closed-loop artificial pancreas," Diab. Tech. Ther., vol.7, pp. 28-47, 2005.
31. L. Magni, D. M. Raimondo, L. Bossi, C. Dalla Man, G. De Nicolao, B.Kovatchev, and C. Cobelli, "Model predictive control of type 1 diabetes: An in silico trial," J. Diab. Sci. Tech., vol.1, pp. 804-812, 2007.
32. G. Marchetti, M. Barolo, L. Jovanovic, H. Zisser, and D. E. Seborg, "An improve PID switching control strategy for type 1 diabetes," IEEE Trans. Biom. Eng., vol.55, no.12, pp. 857-865, Dec. 2008. (Pubitemid 351301242)
33. A. Gentilini, C. Schaniel, M. Morari, C. Bieniok, R. Wymann, and T. Schnider, "A new paradigm for closed-loop intraoperative administration of analgesics in humans," IEEE Trans. Biom. Eng., vol.49, no.4, pp. 289-299, Apr. 2002. (Pubitemid 34241387)
34. C. M. Ionescu, R. D. Keyser, B. C. Torrico, T. De Smet, M. M. Struys, and J. E. Normey-Rico, "Robust predictive control strategy applied for propofol dosing using bis as a controlled variable during anesthesia," IEEE Trans. Biom. Eng., vol.55, no.9, pp. 2161-2170, Sep. 2008.
35. A. L. G. Caruso, T. W. Bouillon, P. M. Schumacher, E. Zanderigo, and M. Morari, "Control of drug administration during monitored anesthesia care," IEEE Trans. Auto. Sci. Eng., vol.6, no.2, pp. 256-264, Apr. 2009.
36. G. Pannocchia and A. Brambilla, "Model predictive control for optimal oral anticoagulant drug administration," AIChE J., vol.52, pp. 3315-3320, 2006. (Pubitemid 44368715)
37. T. J. McAvoy, "IV. Modelling and control of the anticoagulant drug heparin," J. Proc. Cont., vol.17, pp. 590-594, 2007.
38. M. E. Brandt and G. Chen, "Feedback control of a biodynamical model of HIV-1," IEEE Trans. Biom. Eng., vol.48, no.7, pp. 754-759, Jul. 2005.
39. S. S. Ge, Z. Tian, and T. H. Lee, "Nonlinear control of a dynamic model of HIV-1," IEEE Trans. Biom. Eng., vol.52, no.3, pp. 353-361, Mar. 2005. (Pubitemid 40343732)
40. E. Palacios, G. Espinosa-Ṕerez, and D. U. Campos-Delgado, "A passivitybased approach for HIV-1 treatment scheduling," in Proc. Amer. Cont. Conf., New York City, 2007, pp. 4106-4111.
41. V. M. Zavala and L. T. Biegler, "The advanced-step NMPC controller: Optimality, stability and robustness," Automatica, vol.45, no.1, pp. 86-93, 2009.
42. S. Boyd, "Real-time embedded convex optimization," in Proc. ADCHEM 2009 (IFAC Symp. Adv. Cont. Chem. Proc.), S. Engell and Y. Arkun, Eds. vol.I, 2009, p. 10.
43. H. J. Ferreau, H. G. Bock, and M. Diehl, "An online active set strategy to overcome the limitations of explicit mpc," Int. J. Rob. Nonl. Cont., vol.18, no.8, pp. 816-830, 2008. (Pubitemid 351743519)
44. G. Pannocchia, J. B. Rawlings, and S. J. Wright, "Fast, large-scale model predictive control by partial enumeration," Automatica, vol.43, no.5, pp. 852-860, 2007. (Pubitemid 46507426)
45. P. O. M. Scokaert and J. B. Rawlings, "Feasibility issues in linear model predictive control," AIChE J., vol.45, pp. 1649-1659, 1999. (Pubitemid 29382580)
46. S. Audoly, G. Bellu, L.D'Angìo, M. P. Saccomani, and C. Cobelli, "Global identifiability of nonlinear models of biological systems," IEEE Trans. Biom. Eng., vol.48, no.1, pp. 55-65, Jan. 2001. (Pubitemid 32165710)
47. X. Xia and C. H. Moog, "Identifiability of nonlinear systems with application to HIV/AIDS models," IEEE Trans. Auto. Contr., vol.48, no.2, pp. 330-336, Feb. 2003.